ConductScience.org, home

Paper31981925

R-Roscovitine Improves Motoneuron Function in Mouse Models for Spinal Muscular Atrophy.

Tejero R and 14 others. iScience, 2020. Cited by 20 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. R-Roscovitine Improves Motoneuron Function in Mouse Models for Spinal Muscular Atrophy. Papers, record 31981925. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31981925

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
R-Roscovitine Improves Motoneuron Function in Mouse Models for Spinal Muscular Atrophy.
PubMed
Journal
iScience
PubMed
Year
2020
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
20
iCite
Relative citation ratio, by iCite
0.94
iCite
Revised in PubMed
2021-01-10
PubMed

Authors15

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Tejero RRocio
2Balk SStefanie
3Franco-Espin JJulio
4Ojeda JJorge
5Hennlein LLuisa
6Drexl HHans
7Dombert BBenjamin
8Clausen JDJan-Dierk
9Torres-Benito LLaura
10Saal-Bauernschubert LLena
11Blum RRobert
12Briese MMichael
13Appenzeller SSilke
14Tabares LLucia
15Jablonka SSibylle

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References65

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
118,216,203Exercise-induced activation of NMDA receptor promotes motor unit development and survival in a type 2 spinal muscular atrophy model mouse.J Neurosci2008https://conductscience.org/library/papers/18216203PubMed
229,091,557Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy.N Engl J Med2017https://conductscience.org/library/papers/29091557PubMed
328,504,671Reduced sensory synaptic excitation impairs motor neuron function via Kv2.1 in spinal muscular atrophy.Nat Neurosci2017https://conductscience.org/library/papers/28504671PubMed
417,923,533Defective Ca2+ channel clustering in axon terminals disturbs excitability in motoneurons in spinal muscular atrophy.J Cell Biol2007https://conductscience.org/library/papers/17923533PubMed
524,011,867Targeting cyclin-dependent kinases in anti-neoplastic therapy.Curr Opin Cell Biol2013https://conductscience.org/library/papers/24011867PubMed
69,845,364A novel function for SMN, the spinal muscular atrophy disease gene product, in pre-mRNA splicing.Cell1998https://conductscience.org/library/papers/9845364PubMed
726,987,072Modulating Innate and Adaptive Immunity by (R)-Roscovitine: Potential Therapeutic Opportunity in Cystic Fibrosis.J Innate Immun2016https://conductscience.org/library/papers/26987072PubMed
817,970,192Effect of L-type calcium channel blockers on activity of newly formed synapses in mice.Bull Exp Biol Med2007https://conductscience.org/library/papers/17970192PubMed
99,207,792Correlation between severity and SMN protein level in spinal muscular atrophy.Nat Genet1997https://conductscience.org/library/papers/9207792PubMed
1014,623,865Smn, the spinal muscular atrophy-determining gene product, modulates axon growth and localization of beta-actin mRNA in growth cones of motoneurons.J Cell Biol2003https://conductscience.org/library/papers/14623865PubMed
118,994,064Novel modulatory effect of L-type calcium channels at newly formed neuromuscular junctions.J Neurosci1997https://conductscience.org/library/papers/8994064PubMed
1222,805,911Calcium channel auxiliary α2δ and β subunits: trafficking and one step beyond.Nat Rev Neurosci2012https://conductscience.org/library/papers/22805911PubMed
1318,485,868SMN deficiency causes tissue-specific perturbations in the repertoire of snRNAs and widespread defects in splicing.Cell2008https://conductscience.org/library/papers/18485868PubMed
1415,657,360Metabolism and pharmacokinetics of the cyclin-dependent kinase inhibitor R-roscovitine in the mouse.Mol Cancer Ther2005https://conductscience.org/library/papers/15657360PubMed
1519,158,308Impaired synaptic vesicle release and immaturity of neuromuscular junctions in spinal muscular atrophy mice.J Neurosci2009https://conductscience.org/library/papers/19158308PubMed
1611,923,424Cdk5/p35 regulates neurotransmitter release through phosphorylation and downregulation of P/Q-type voltage-dependent calcium channel activity.J Neurosci2002https://conductscience.org/library/papers/11923424PubMed
1723,063,130SMN is required for sensory-motor circuit function in Drosophila.Cell2012https://conductscience.org/library/papers/23063130PubMed
1828,173,138Synaptotagmin-2, and -1, linked to neurotransmission impairment and vulnerability in Spinal Muscular Atrophy.Hum Mol Genet2016https://conductscience.org/library/papers/28173138PubMed
1923,785,168Evaluation of a novel calcium channel agonist for therapeutic potential in Lambert-Eaton myasthenic syndrome.J Neurosci2013https://conductscience.org/library/papers/23785168PubMed
2025,246,652Subcellular transcriptome alterations in a cell culture model of spinal muscular atrophy point to widespread defects in axonal growth and presynaptic differentiation.RNA2014https://conductscience.org/library/papers/25246652PubMed

See all 65 references

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.

PMIDTitleJournalYearIn PapersSource
41,872,133The amino acid transporter LAT1 coordinates proper motor function at the perinatal stage.Cell Death Dis2026https://conductscience.org/library/papers/41872133PubMed
41,028,013Munc13-1 restoration mitigates presynaptic pathology in spinal muscular atrophy.Nat Commun2025https://conductscience.org/library/papers/41028013PubMed
40,906,176Managing Spinal Muscular Atrophy: A Look at the Biology and Treatment Strategies.Biology (Basel)2025https://conductscience.org/library/papers/40906176PubMed
40,038,284Functional optic tract rewiring via subtype- and target-specific axonal regeneration and presynaptic activity enhancement.Nat Commun2025https://conductscience.org/library/papers/40038284PubMed
39,666,039Cytoskeleton dysfunction of motor neuron in spinal muscular atrophy.J Neurol2024https://conductscience.org/library/papers/39666039PubMed
39,596,381Roscovitine, a CDK Inhibitor, Reduced Neuronal Toxicity of mHTT by Targeting HTT Phosphorylation at S1181 and S1201 In Vitro.Int J Mol Sci2024https://conductscience.org/library/papers/39596381PubMed
38,269,114Impaired communication at the neuromotor axis during Degenerative Cervical Myelopathy.Front Cell Neurosci2023https://conductscience.org/library/papers/38269114PubMed
38,249,130The SMA Modifier Plastin 3 Targets Cell Membrane-Associated Proteins in Motoneurons.Neurosci Insights2024https://conductscience.org/library/papers/38249130PubMed
37,976,261Mitigating aberrant Cdk5 activation alleviates mitochondrial defects and motor neuron disease symptoms in spinal muscular atrophy.Proc Natl Acad Sci U S A2023https://conductscience.org/library/papers/37976261PubMed
37,108,811Nifedipine Ameliorates Cellular Differentiation Defects of Smn-Deficient Motor Neurons and Enhances Neuromuscular Transmission in SMA Mice.Int J Mol Sci2023https://conductscience.org/library/papers/37108811PubMed
36,607,273Plastin 3 rescues cell surface translocation and activation of TrkB in spinal muscular atrophy.J Cell Biol2023https://conductscience.org/library/papers/36607273PubMed
35,966,199The role of Cdk5 in neurological disorders.Front Cell Neurosci2022https://conductscience.org/library/papers/35966199PubMed
34,983,696Therapy development for spinal muscular atrophy: perspectives for muscular dystrophies and neurodegenerative disorders.Neurol Res Pract2022https://conductscience.org/library/papers/34983696PubMed
34,337,562Spinal muscular atrophy: From approved therapies to future therapeutic targets for personalized medicine.Cell Rep Med2021https://conductscience.org/library/papers/34337562PubMed
33,693,569Calcium is reduced in presynaptic mitochondria of motor nerve terminals during neurotransmission in SMA mice.Hum Mol Genet2021https://conductscience.org/library/papers/33693569PubMed
33,562,482In Search of a Cure: The Development of Therapeutics to Alter the Progression of Spinal Muscular Atrophy.Brain Sci2021https://conductscience.org/library/papers/33562482PubMed
33,281,605Drug Screening and Drug Repositioning as Promising Therapeutic Approaches for Spinal Muscular Atrophy Treatment.Front Pharmacol2020https://conductscience.org/library/papers/33281605PubMed
32,848,618The Mouse Levator Auris Longus Muscle: An Amenable Model System to Study the Role of Postsynaptic Proteins to the Maintenance and Regeneration of the Neuromuscular Synapse.Front Cell Neurosci2020https://conductscience.org/library/papers/32848618PubMed

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CACNA1A773PubTator's text mininghttps://conductscience.org/library/genes/773NCBI Gene
CACNA1B774PubTator's text mininghttps://conductscience.org/library/genes/774NCBI Gene
SMN16,606PubTator's text mininghttps://conductscience.org/library/genes/6606NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/31981925

GET https://conductscience.org/api/papers/v1/31981925/references?page=2